Evidence map›Paper›PMID 19110503›Full record

ReviewCirculation journal : official journal of the Japanese Circulation Society2009

Novel aspects of oxidative stress in cardiovascular diseases.

Donald D Heistad, Yoshinobu Wakisaka, Jordan Miller, Yi Chu, Ricardo Pena-Silva

Abstract readReview
In one paragraph

Review in Circulation journal : official journal of the Japanese Circulation Society, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Mechanism of Hypercholesterolemia-Induced Atherosclerosis.Reviews in cardiovascular medicine · 2022
    Review
  10. Article
  11. Article
  12. Review
  13. Pharmaceuticals (Basel, Switzerland) · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Update on Pharmacological Activities, Security, and Pharmacokinetics of Rhein.Evidence-based complementary and alternative medicine : eCAM · 2021
    Review
  18. Article
  19. Article
  20. Porphyrin-Based SOD Mimic MnTnBu OE -2-PyPJournal of the American Heart Association · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Donald D HeistadDepartments of Internal Medicine, University of Iowa Carver College of Medicine, 52242-1081, USA. Donald-heistad@uiowa.edu
Yoshinobu Wakisaka
Jordan Miller
Yi Chu
Ricardo Pena-Silva

Funding

Vascular Protection During HypertensionP01HL062984 · NHLBI · UNIVERSITY OF IOWA · PI SIGMUND, CURT DANIEL · 2000 to 2015
$22.2M
Transgenic and knockout animalP01NS024621 · NINDS · UNIVERSITY OF IOWA · PI SANFORD, L PHILLIP · 1987 to 2012
$14.9M
NHLBI NIH HHS HL-62984NHLBI NIH HHS P01 HL062984NINDS NIH HHS NS-24621NINDS NIH HHS P01 NS024621
6 · The paper itself

Abstract

Oxygen radicals, and other reactive oxygen species, may play an important role in the pathophysiology of atherosclerosis, stroke, and other cardiovascular diseases. Mechanisms that account for oxidative stress in different cardiovascular diseases are diverse; for example, increases in activity of NAD(P)H oxidase, "uncoupling" of nitric oxide synthase, and maladaptive changes in expression of antioxidants can all contribute to increases in oxidative stress. Very different patterns of pro-and antioxidant mechanisms that contribute to increases in oxygen radicals in atherosclerotic plaques, hemorrhagic strokes, and aortic valve stenosis have been observed. A disappointment, in relation to the hypothesis that oxygen radicals contribute to cardiovascular risk, is that many studies indicate that antioxidant vitamins fail to reduce the risk of cardiovascular disease. Better understanding of mechanisms that lead to increases in oxidative stress in different cardiovascular diseases may lead to more effective antioxidant prevention or treatment of diseases.

Indexed as

AnimalsAntioxidantsCardiovascular DiseasesDisease Models, AnimalGenetic VariationHumansMiceOxidative StressReactive Oxygen SpeciesSuperoxide DismutaseAntioxidantsReactive Oxygen SpeciesSuperoxide Dismutase

Identifiers

PMID19110503
PMCPMC2860751

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.